Nuformix (LSE:NFX) Total Stockholders Equity : £0.81 Mil (As of Mar. 2025)

View and export this data going back to 2015. Start your Free Trial

What is Nuformix Total Stockholders Equity?

Nuformix's Total Stockholders Equity for the quarter that ended in Mar. 2025 was £0.81 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Nuformix's Book Value per Share for the quarter that ended in Mar. 2025 was £0.00. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Nuformix's Debt-to-Equity for the quarter that ended in Mar. 2025 was 0.00.

Nuformix Total Stockholders Equity Historical Data

The historical data trend for Nuformix's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nuformix Total Stockholders Equity Chart

Nuformix Annual Data

Trend

Dec15

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Sep24

Total Stockholders Equity

Get a 7-Day Free Trial

4.74

5.69

4.74

4.23

0.72

Nuformix Semi-Annual Data
	Dec15	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Mar24	Sep24	Mar25
Total Stockholders Equity	Get a 7-Day Free Trial													4.59	4.23	4.10	0.72	0.81

Nuformix (LSE:NFX) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Nuformix's Book Value per Share for the quarter that ended in Mar. 2025 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(0.808	-	0)	/	1695.709
	=	0.00

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Nuformix's Debt-to-Equity for the quarter that ended in Mar. 2025 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0)	/	0.808
	=	0.00

Nuformix Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Nuformix's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Nuformix Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nuformix PLC (LSE:NFX) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

60 Gracechurch Street, 6th Floor, London, GBR, EC3V 0HR

Website

https://www.nuformix.com

Nuformix PLC is a pharmaceutical development company. It operates in the field of pharmaceutical development targeting unmet medical needs in fibrosis and oncology via drug repurposing. Its pipeline products include NXP001, NXP002, and NXP004. Geographically, the company operates only in the UK.